|
|
| November 11, 2008: Dr. Matthias Friedrich and Dr. C Michael Gibson discuss the role of cardiac magnetic resonance in clinical practice |
Dr. Matthias Friedrich and Dr. C. Michael Gibson discuss the
role of cardiac magnetic resonance in clinical practice at
the 2008 AHA Scientific Sessions
Disclosures for Dr. Gibson at the time of filming:
Present Research/Grant Funding
Schering Plough Corporation; Sanofi-Aventis; Baxter; FoldRx;
Genentech, Inc.; Astra Zeneca; HeartScape Technologies; Fold
Rx;
Abbott; Cardica, Inc.; Johnson & Johnson Corporation;
FibroGen, Inc.
Speakers Bureau
Schering Plough Corporation; Eli Lilly and Company; Daiichi
Sankyo Company, Inc;
Consultant
The Medicines Company; Bayer Corporation; Archemix
Corporation;
Heartscape Technologies, Inc.; Angel Medical Systems;
Schering Plough
Corporation; Portola Corporation; John & Johnson
Corporation; ICON
Medical Imaging; Jim Moran Heart and Vascular Research
Institute
Stock Ownership
My wife owns stock in HealthMarx Inc.
Royalties as a Contributor
UpToDate in Cardiovascular Medicine
Past Research/Grant Funding/Past Speakers Bureau/Past
Consulting
ActivBiotics, Inc.; Acusphere, Inc.; Astra; Sanofi-Aventis
Corporation; Bard Corporation; Boston Scientific
Corporation; Bristol
Meyers Squibb Company; British Biotech, plc.; Ciba Geigy
Corporation;
Corgentech, Inc.; COR Therapeutics; DVI Guidant Corporation;
GlaxoSmithKline; Genentech, Inc.; Merck & Co., Inc.;
Millennium
Pharmaceuticals; NIH; Pfizer; Percusurge, Inc.; Smith Kline
Beecham;
Sonus; St. Jude Medical; timi3 Systems, Inc.; Ascenta
Therapeutics,
Inc; CardioKinetix, Inc.; Eli Lilly and Company; KAI
Pharmaceuticals;
Nuvelo; INO Therapeutics, LLC; Point Biomedical Corporation;
Portola
Pharmaceuticals, Inc.; The Medicines Company; Ascenta
Therapeutics;
Atrium Medical Corporation; Biogen IDEC; PDL
Pharmaceuticals; timi3
Systems; Momenta Pharmaceuticals; Novartis Corporation;
Current disclosures for Dr. Gibson can be found at:
http://en.wikidoc.org/index.php/C._Michael_Gibson
[ Download video ] |
|
No comments have been submitted
|